Evotec SE (EVO) Cost of Revenue (2009 - 2025)
Evotec SE (EVO) reported Cost of Revenue of $203474.8 for Q4 2025, up 8.75% on a YoY basis from $187111.1 in Q4 2024, and up 6.16% sequentially from $191665.4 in Q3 2025.
Evotec SE (EVO) Cost of Revenue (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of Cost of Revenue data on file, last reported at $203474.8 in Q4 2025.
- For the quarter ending Q4 2025, Cost of Revenue rose 8.75% year-over-year to $203474.8; the trailing twelve-month figure through Dec 2025 stood at $765222.3 (down 24.9% YoY), and the FY2025 full-year result was $784798.1, up 7.67% from the prior year.
- Cost of Revenue grew to $203474.8 in Q4 2025, from $191665.4 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $476349.8 in Q4 2023 to a low of $123525.8 in Q1 2021.
- A 5-year average of $215867.9 and a median of $174575.3 in 2023 frame the typical range for Cost of Revenue.
- Peak annual rise in Cost of Revenue reached 26.06% in 2021, while the deepest fall reached 99.88% in 2021.
- Tracing EVO's Cost of Revenue over 5 years: stood at $379219.5 in 2021, then advanced by 12.77% to $427636.7 in 2022, then rose by 11.39% to $476349.8 in 2023, then slumped by 60.72% to $187111.1 in 2024, then advanced by 8.75% to $203474.8 in 2025.
- Business Quant data shows EVO's Cost of Revenue at $203474.8 in Q4 2025, $191665.4 in Q3 2025, and $187111.1 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Evotec SE | 339.17 Mn | 338.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 203,474.81 |
| Dec 31, 2025 | 203,474.81 |
| Sep 30, 2025 | 191,665.41 |
| Sep 30, 2025 | 191,665.41 |
| Dec 31, 2024 | 187,111.05 |
| Dec 31, 2024 | 187,111.05 |
| Sep 30, 2024 | 182,971.06 |
| Sep 30, 2024 | 182,971.06 |
| Dec 31, 2023 | 476,349.80 |
| Dec 31, 2023 | 476,349.80 |
| Sep 30, 2023 | 172,491.52 |
| Sep 30, 2023 | 172,491.52 |
| Jun 30, 2023 | 174,575.27 |
| Jun 30, 2023 | 174,575.27 |
| Dec 31, 2022 | 427,636.68 |
| Dec 31, 2022 | 427,636.68 |
| Sep 30, 2022 | 146,667.62 |
| Sep 30, 2022 | 146,667.62 |
| Jun 30, 2022 | 150,783.65 |
| Jun 30, 2022 | 150,783.65 |